Invention Grant
- Patent Title: Phospholipase C mutant and use thereof
-
Application No.: US15035105Application Date: 2014-11-04
-
Publication No.: US10144919B2Publication Date: 2018-12-04
- Inventor: Jun Xu , Yaoji Xuan , Jinmin Li
- Applicant: Wilmar (Shanghai) Biotechnology Research & Development Center Co., LTD
- Applicant Address: CN
- Assignee: Wilmar (Shanghai) Biotechnology Research & Development Center Co., LTD
- Current Assignee: Wilmar (Shanghai) Biotechnology Research & Development Center Co., LTD
- Current Assignee Address: CN
- Agency: St. Onge Steward Johnston & Reens, LLC
- Priority: CN201310548632 20131107
- International Application: PCT/CN2014/090213 WO 20141104
- International Announcement: WO2015/067161 WO 20150514
- Main IPC: C12N9/16
- IPC: C12N9/16 ; C11B3/00 ; A23D7/04 ; A23D9/04 ; C12N9/48 ; C12N9/20

Abstract:
The present application provides mutants of wild type phospholipase C (PLC) specific to phosphatidylcholine from Bacillus cereus. The related mutations include mutation of asparagine at position 63 to another amino acid, also including mutation of arginine at position 20 to histidine and of alanine at position 83 to aspartic acid. The present application also provides a nucleic acid molecule encoding the mutant, a vector containing the nucleic acid molecule, and a cell containing the nucleic acid molecule or vector. The present application also provides uses of the mutant, nucleic acid molecule vector, and cell.
Public/Granted literature
- US20160362665A1 Phospholipase C Mutant And Use Thereof Public/Granted day:2016-12-15
Information query